Eli Lilly and Company: Osteoporosis trials

The registry lists 23 Osteoporosis studies with Eli Lilly and Company as lead sponsor. 0 are open to participants now and 14 have results posted.

Phase 2 4Phase 3 8Phase 4 8No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With OsteoporosisCompletedNCT01753856Phase 4Results posted
• A Study of Teriparatide in Japanese Osteoporosis PatientsCompletedNCT01430104Phase 4Results posted
• A Study of LY2541546 in Women With Low Bone Mineral DensityCompletedNCT01144377Phase 2Results posted
• Study of FORTEO Use in Subjects in the Community SettingCompletedNCT01078805Results posted
• A Study for the Transdermal Application of TeriparatideCompletedNCT01011556Phase 2Results posted
• Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic WomenCompletedNCT00927186Phase 4Results posted
• A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip FractureCompletedNCT00887354Phase 4Results posted
• Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide TherapyCompletedNCT00577863Phase 3Results posted
• A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With TeriparatideCompletedNCT00557310Phase 4Results posted
• Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced OsteoporosisCompletedNCT00503399Phase 3Results posted
• Phase 3 Clinical Trial of Teriparatide in JapanCompletedNCT00433160Phase 3Results posted
• A Study for Patients With OsteoporosisCompletedNCT00414973Phase 3Results posted
• Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With OsteoporosisCompletedNCT00259298Phase 4Results posted
• Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced OsteoporosisCompletedNCT00051558Phase 3Results posted
• The Forteo Alendronate Comparator TrialCompletedNCT02416271Phase 4
• A Study of Arzoxifene to Treat Korean Women With OsteoporosisCompletedNCT00767299Phase 2
• Back Pain in Patients With Severe OsteoporosisCompletedNCT00761332
• A Study for Teriparatide in Severe OsteoporosisCompletedNCT00696644
• Bone Effects of Teriparatide Following AlendronateCompletedNCT00191893Phase 3
• Clinical Trial of Teriparatide in JapanCompletedNCT00191867Phase 2
• Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic PatientsCompletedNCT00191802Phase 3
• Teriparatide Use in Hip Replaced SubjectsCompletedNCT00191321Phase 3
• EVA: Evista Alendronate ComparisonCompletedNCT00035971Phase 4